Aaron Sheppard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Aaron Sheppard has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Babak Saboury
Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland
2 shared publications - Kelly Lauter Roszko
Mineral Homeostasis Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health , Bethesda, MD 20892
2 shared publications - Michael Terrence Collins
Skeletal Disorders and Mineral Homeostasis Section, National Institute of Dental and Craniofacial Research, National Institutes of Health
2 shared publications - Rachel Ilana Gafni
National Institute of Dental and Craniofacial Research, NIH , Bethesda, MD 20892, United States
2 shared publications - Alex P. Percle
Louisiana State University Health Shreveport, Department of Orthopaedic Surgery, Shreveport, Louisiana
1 shared publication - Austin W. Hansen
Department of Orthopaedic Surgery, Louisiana State University Health Sciences Shreveport, Shreveport, Louisiana
1 shared publication
Latest Publications
- Open Access
- 17 September 2025
- Published by Elsevier in JSES International
- Vol. 10 (1) , 101381
Clinical outcomes of modular segmental megaprosthesis for revision shoulder arthroplasty with severe proximal humerus bone loss at a minimum two year follow-up
- 17 September 2025
- Published by Elsevier in JSES International
- Vol. 10 (1) , 101381
Open AccessClinical outcomes of modular segmental megaprosthesis for revision shoulder arthroplasty with severe proximal humerus bone loss at a minimum two year follow-up
- Open Access
- 1 April 2025
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 10 (2)
What Sets Indexed Orthopaedic Journals Apart? A Comparative Analysis of Quality Metrics Between Indexed Orthopaedic Journals and Nonindexed Orthopaedic Journals
Introduction: The PubMed database is used by many organizations as the benchmark for quality publications. This study aimed to identify quality metrics distinguishing orthopaedic journals indexed in PubMed from nonindexed journals. A second aim was to compare metrics of orthopaedic journals indexed in other major databases vs. nonindexed journals. We hypothesized that indexed orthopaedic journals would have several measurable attributes differentiating them from nonindexed journals. Methods: A list of all current orthopaedic journals in publication in 2021 was compiled. The journals were characterized based on their index status in PubMed, Master Journal List, Journal Citation Reports (JCR), MEDLINE, or Directory of Open Access Journals. Various journal attributes were collected and compared by indexed status. Each variable's association with indexed journals was determined through statistical analysis. Results: Of 478 evaluated journals, 271 were indexed by PubMed. Univariate analysis demonstrated significant associations between PubMed indexing and society affiliation, physician editorial leadership, print version availability, subscription availability, impact factor (IF) listed in JCR, use of Creative Commons licenses, Committee on Publication Ethics (COPE) membership, journals that require an article processing charge (APC), and earlier year of first issue (all with p < 0.001). Logistic regression of journals listed in any index demonstrates that COPE membership had the highest impact on indexed status (odds ratio = 34.19; 95% confidence interval 5.69-105.59; p < 0.001). The regression model also demonstrated that society affiliation, subscription availability, MD designation on website for editors, year of first issue, and number of physician editors have significant associations with indexed journals. Conclusion: COPE membership was the most distinguishing characteristic of indexed orthopaedic journals. Physician editorial leadership and society affiliation were also strong predictors of a journal having an indexed status. In addition, having a print version and/or subscription available, use of Creative Commons licenses, higher IF, longer publication history, and higher APC charge were associated more frequently with indexed journals. Authors should consider these factors when submitting articles to a journal and use caution submitting to journals which do not meet these quality metrics.
- 1 April 2025
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 10 (2)
Open AccessWhat Sets Indexed Orthopaedic Journals Apart? A Comparative Analysis of Quality Metrics Between Indexed Orthopaedic Journals and Nonindexed Orthopaedic Journals
Introduction: The PubMed database is used by many organizations as the benchmark for quality publications. This study aimed to identify quality metrics distinguishing orthopaedic journals indexed in PubMed from nonindexed journals. A second aim was to compare metrics of orthopaedic journals indexed in other major databases vs. nonindexed journals. We hypothesized that indexed orthopaedic journals would have several measurable attributes differentiating them from nonindexed journals. Methods: A list of all current orthopaedic journals in publication in 2021 was compiled. The journals were characterized based on their index status in PubMed, Master Journal List, Journal Citation Reports (JCR), MEDLINE, or Directory of Open Access Journals. Various journal attributes were collected and compared by indexed status. Each variable's association with indexed journals was determined through statistical analysis. Results: Of 478 evaluated journals, 271 were indexed by PubMed. Univariate analysis demonstrated significant associations between PubMed indexing and society affiliation, physician editorial leadership, print version availability, subscription availability, impact factor (IF) listed in JCR, use of Creative Commons licenses, Committee on Publication Ethics (COPE) membership, journals that require an article processing charge (APC), and earlier year of first issue (all with p < 0.001). Logistic regression of journals listed in any index demonstrates that COPE membership had the highest impact on indexed status (odds ratio = 34.19; 95% confidence interval 5.69-105.59; p < 0.001). The regression model also demonstrated that society affiliation, subscription availability, MD designation on website for editors, year of first issue, and number of physician editors have significant associations with indexed journals. Conclusion: COPE membership was the most distinguishing characteristic of indexed orthopaedic journals. Physician editorial leadership and society affiliation were also strong predictors of a journal having an indexed status. In addition, having a print version and/or subscription available, use of Creative Commons licenses, higher IF, longer publication history, and higher APC charge were associated more frequently with indexed journals. Authors should consider these factors when submitting articles to a journal and use caution submitting to journals which do not meet these quality metrics.
- Open Access
- 24 July 2024
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 39 (9) , 1327-1339
Structural and molecular imaging-based characterization of soft tissue and vascular calcification in hyperphosphatemic familial tumoral calcinosis
Hyperphosphatemic Familial Tumoral Calcinosis (HFTC) is a rare disorder caused by deficient FGF23 signaling and resultant ectopic calcification. In this study, we systematically characterized and quantified macro- and micro-calcification in an HFTC cohort using computed tomography (CT) and 18F-sodium fluoride positron emission tomography/CT (18F-NaF PET/CT). Fourier-transform infrared (FTIR) spectroscopy was performed on four phenotypically different calcifications from a patient with HFTC, showing the dominant component to be hydroxyapatite. Eleven patients with HFTC were studied with CT and/or 18F-NaF PET/CT. Qualitative review was done to describe the spectrum of imaging findings on both modalities. CT-based measures of volume (e.g., total calcific burden and lesion volume) and density (Hounsfield units) were quantified and compared to PET-based measures of metabolic activity (e.g., mean standardized uptake values). Microcalcification scores (mCSs) were calculated for the vasculature of six patients using 18F-NaF PET/CT and visualized on a standardized vascular atlas. Ectopic calcifications were present in 82% of patients, predominantly near joints and the distal extremities. Considerable heterogeneity was observed in total calcific burden per patient (823.0 ± 670.1 cm3, n = 9) and lesion volume (282.5 ± 414.8 cm3, n = 27). The largest lesions were found at the hips and shoulders. 18F-NaF PET offered the ability to differentiate active vs. quiescent calcifications. Calcifications were also noted in multiple anatomic locations, including brain parenchyma (50%). Vascular calcification was seen in the distal aorta, carotid, and coronaries in 50%, 70%, 73%, and 50%, respectively. 18F-NaF-avid, but CT-negative calcification was seen in a 17-year-old patient, implicating early onset vascular calcification. This first systematic assessment of calcifications in a cohort of patients with HFTC has identified the early onset, prevalence, and extent of macro- and micro-calcification. It supports 18F-NaF PET/CT as a clinical tool for distinguishing between active and inactive calcification, informing disease progression, and quantification of ectopic and vascular disease burden. Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare disorder in which patients develop sometimes large debilitating calcifications of soft tissues and blood vessels. It is caused by deficient fibroblast growth factor-23 that leads to high phosphate levels, which contributes to the calcifications. The calcifications and manifestations of this disorder have not been well characterized. We determined the mineral composition of the calcifications to be hydroxyapatite. Capitalizing on the fact fluoride can be integrated into hydroxyapatite, we used radiolabeled sodium fluoride positron emission tomography/computed tomography scans (18F-NaF PET/CT) to characterize and quantify the calcifications in 11 patients. 82% of the patients had calcifications, with the largest located at the hips and shoulders. Micro-calcifications were found in the blood vessels of most patients, including children. The technique also enabled us to differentiate between active versus stable calcifications. This first systematic assessment of calcifications in patients with HFTC showed the utility of 18F-NaF PET/CT as a tool to identify and quantify calcifications, as well as distinguish between active and stable calcifications. This approach will inform disease progression and may prove useful for measuring response to treatment.
- 24 July 2024
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 39 (9) , 1327-1339
Open AccessStructural and molecular imaging-based characterization of soft tissue and vascular calcification in hyperphosphatemic familial tumoral calcinosis
Hyperphosphatemic Familial Tumoral Calcinosis (HFTC) is a rare disorder caused by deficient FGF23 signaling and resultant ectopic calcification. In this study, we systematically characterized and quantified macro- and micro-calcification in an HFTC cohort using computed tomography (CT) and 18F-sodium fluoride positron emission tomography/CT (18F-NaF PET/CT). Fourier-transform infrared (FTIR) spectroscopy was performed on four phenotypically different calcifications from a patient with HFTC, showing the dominant component to be hydroxyapatite. Eleven patients with HFTC were studied with CT and/or 18F-NaF PET/CT. Qualitative review was done to describe the spectrum of imaging findings on both modalities. CT-based measures of volume (e.g., total calcific burden and lesion volume) and density (Hounsfield units) were quantified and compared to PET-based measures of metabolic activity (e.g., mean standardized uptake values). Microcalcification scores (mCSs) were calculated for the vasculature of six patients using 18F-NaF PET/CT and visualized on a standardized vascular atlas. Ectopic calcifications were present in 82% of patients, predominantly near joints and the distal extremities. Considerable heterogeneity was observed in total calcific burden per patient (823.0 ± 670.1 cm3, n = 9) and lesion volume (282.5 ± 414.8 cm3, n = 27). The largest lesions were found at the hips and shoulders. 18F-NaF PET offered the ability to differentiate active vs. quiescent calcifications. Calcifications were also noted in multiple anatomic locations, including brain parenchyma (50%). Vascular calcification was seen in the distal aorta, carotid, and coronaries in 50%, 70%, 73%, and 50%, respectively. 18F-NaF-avid, but CT-negative calcification was seen in a 17-year-old patient, implicating early onset vascular calcification. This first systematic assessment of calcifications in a cohort of patients with HFTC has identified the early onset, prevalence, and extent of macro- and micro-calcification. It supports 18F-NaF PET/CT as a clinical tool for distinguishing between active and inactive calcification, informing disease progression, and quantification of ectopic and vascular disease burden. Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare disorder in which patients develop sometimes large debilitating calcifications of soft tissues and blood vessels. It is caused by deficient fibroblast growth factor-23 that leads to high phosphate levels, which contributes to the calcifications. The calcifications and manifestations of this disorder have not been well characterized. We determined the mineral composition of the calcifications to be hydroxyapatite. Capitalizing on the fact fluoride can be integrated into hydroxyapatite, we used radiolabeled sodium fluoride positron emission tomography/computed tomography scans (18F-NaF PET/CT) to characterize and quantify the calcifications in 11 patients. 82% of the patients had calcifications, with the largest located at the hips and shoulders. Micro-calcifications were found in the blood vessels of most patients, including children. The technique also enabled us to differentiate between active versus stable calcifications. This first systematic assessment of calcifications in patients with HFTC showed the utility of 18F-NaF PET/CT as a tool to identify and quantify calcifications, as well as distinguish between active and stable calcifications. This approach will inform disease progression and may prove useful for measuring response to treatment.
- 1 June 2024
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 44 (6) , 1432-1446
Spatial Atlas for Mapping Vascular Microcalcification Using 18F-NaF PET/CT: Application in Hyperphosphatemic Familial Tumoral Calcinosis
BACKGROUND: Vascular calcification causes significant morbidity and occurs frequently in diseases of calcium/phosphate imbalance. Radiolabeled sodium fluoride positron emission tomography/computed tomography has emerged as a sensitive and specific method for detecting and quantifying active microcalcifications. We developed a novel technique to quantify and map total vasculature microcalcification to a common space, allowing simultaneous assessment of global disease burden and precise tracking of site-specific microcalcifications across time and individuals. METHODS: To develop this technique, 4 patients with hyperphosphatemic familial tumoral calcinosis, a monogenic disorder of FGF23 (fibroblast growth factor-23) deficiency with a high prevalence of vascular calcification, underwent radiolabeled sodium fluoride positron emission tomography/computed tomography imaging. One patient received serial imaging 1 year after treatment with an IL-1 (interleukin-1) antagonist. A radiolabeled sodium fluoride–based microcalcification score, as well as calcification volume, was computed at all perpendicular slices, which were then mapped onto a standardized vascular atlas. Segment-wise mCS mean and mCS max were computed to compare microcalcification score levels at predefined vascular segments within subjects. RESULTS: Patients with hyperphosphatemic familial tumoral calcinosis had notable peaks in microcalcification score near the aortic bifurcation and distal femoral arteries, compared with a control subject who had uniform distribution of vascular radiolabeled sodium fluoride uptake. This technique also identified microcalcification in a 17-year-old patient, who had no computed tomography–defined calcification. This technique could not only detect a decrease in microcalcification score throughout the patient treated with an IL-1 antagonist but it also identified anatomic areas that had increased responsiveness while there was no change in computed tomography–defined macrocalcification after treatment. CONCLUSIONS: This technique affords the ability to visualize spatial patterns of the active microcalcification process in the peripheral vasculature. Further, this technique affords the ability to track microcalcifications at precise locations not only across time but also across subjects. This technique is readily adaptable to other diseases of vascular calcification and may represent a significant advance in the field of vascular biology.
- 1 June 2024
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 44 (6) , 1432-1446
Spatial Atlas for Mapping Vascular Microcalcification Using 18F-NaF PET/CT: Application in Hyperphosphatemic Familial Tumoral Calcinosis
BACKGROUND: Vascular calcification causes significant morbidity and occurs frequently in diseases of calcium/phosphate imbalance. Radiolabeled sodium fluoride positron emission tomography/computed tomography has emerged as a sensitive and specific method for detecting and quantifying active microcalcifications. We developed a novel technique to quantify and map total vasculature microcalcification to a common space, allowing simultaneous assessment of global disease burden and precise tracking of site-specific microcalcifications across time and individuals. METHODS: To develop this technique, 4 patients with hyperphosphatemic familial tumoral calcinosis, a monogenic disorder of FGF23 (fibroblast growth factor-23) deficiency with a high prevalence of vascular calcification, underwent radiolabeled sodium fluoride positron emission tomography/computed tomography imaging. One patient received serial imaging 1 year after treatment with an IL-1 (interleukin-1) antagonist. A radiolabeled sodium fluoride–based microcalcification score, as well as calcification volume, was computed at all perpendicular slices, which were then mapped onto a standardized vascular atlas. Segment-wise mCS mean and mCS max were computed to compare microcalcification score levels at predefined vascular segments within subjects. RESULTS: Patients with hyperphosphatemic familial tumoral calcinosis had notable peaks in microcalcification score near the aortic bifurcation and distal femoral arteries, compared with a control subject who had uniform distribution of vascular radiolabeled sodium fluoride uptake. This technique also identified microcalcification in a 17-year-old patient, who had no computed tomography–defined calcification. This technique could not only detect a decrease in microcalcification score throughout the patient treated with an IL-1 antagonist but it also identified anatomic areas that had increased responsiveness while there was no change in computed tomography–defined macrocalcification after treatment. CONCLUSIONS: This technique affords the ability to visualize spatial patterns of the active microcalcification process in the peripheral vasculature. Further, this technique affords the ability to track microcalcifications at precise locations not only across time but also across subjects. This technique is readily adaptable to other diseases of vascular calcification and may represent a significant advance in the field of vascular biology.